Tilray Brands, Inc. (TLRY) stock
TLRYNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends May 31
Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 11/3086% below fair value
$2.43−0.06 (-2.41%)
Close on Nov 13, 2026Market cap $359.12MP/E –Yield –
Tilray Brands profit margin
Profit margin (net margin) is net income as a percentage of revenue.
Tilray Brands's profit margin for the twelve months ending Aug 31, 2026 was -17.1%. For fiscal 2026 it was -13.3%, against -266.3% the year before. The highest annual figure on record is -13.3% in fiscal 2026.
Annual profit margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2026 | May 31, 2026 | -13.3% | +253.0 |
| FY2025 | May 31, 2025 | -266.3% | −235.2 |
| FY2024 | May 31, 2024 | -31.1% | +200.6 |
| FY2023 | May 31, 2023 | -231.6% | −155.8 |
| FY2022 | May 31, 2022 | -75.9% | +116.5 |
| FY2019 | Dec 31, 2019 | -192.3% | −35.3 |
| FY2018 | Dec 31, 2018 | -157.0% | −119.0 |
| FY2017 | Dec 31, 2017 | -38.0% | +24.3 |
| FY2016 | Dec 31, 2016 | -62.3% | – |
Quarterly profit margin
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q1 FY2027CQ3 2026 | Aug 31, 2026 | -16.8% | −16.6 |
| Q4 FY2026CQ2 2026 | May 31, 2026 | -17.6% | +549.3 |
| Q3 FY2026CQ1 2026 | Feb 28, 2026 | -12.9% | +412.1 |
| Q2 FY2026CQ4 2025 | Nov 30, 2025 | -20.7% | +19.8 |
| Q1 FY2026CQ3 2025 | Aug 31, 2025 | -0.2% | +19.4 |
| Q4 FY2025CQ2 2025 | May 31, 2025 | -566.9% | −553.0 |
| Q3 FY2025CQ1 2025 | Feb 28, 2025 | -424.9% | −375.7 |
| Q2 FY2025CQ4 2024 | Nov 30, 2024 | -40.5% | −15.2 |
| Q1 FY2025CQ3 2024 | Aug 31, 2024 | -19.6% | +20.8 |
| Q4 FY2024CQ2 2024 | May 31, 2024 | -13.8% | +61.5 |
| Q3 FY2024CQ1 2024 | Feb 29, 2024 | -49.2% | +755.1 |
| Q2 FY2024CQ4 2023 | Nov 30, 2023 | -25.3% | +22.9 |
| Q1 FY2024CQ3 2023 | Aug 31, 2023 | -40.4% | +7.5 |
| Q4 FY2023CQ2 2023 | May 31, 2023 | -75.3% | +236.5 |
| Q3 FY2023CQ1 2023 | Feb 28, 2023 | -804.3% | −832.8 |
| Q2 FY2023CQ4 2022 | Nov 30, 2022 | -48.2% | −48.1 |
| Q1 FY2023CQ3 2022 | Aug 31, 2022 | -48.0% | −23.2 |
| Q4 FY2022CQ2 2022 | May 31, 2022 | -311.8% | +155.1 |
| Q3 FY2022CQ1 2022 | Feb 28, 2022 | 28.4% | +99.6 |
| Q2 FY2022CQ4 2021 | Nov 30, 2021 | -0.1% | +79.0 |
| Q1 FY2022CQ3 2021 | Aug 31, 2021 | -24.8% | +102.7 |
| Q4 FY2019CQ4 2019 | Dec 31, 2019 | -466.9% | −267.2 |
| Q3 FY2019CQ3 2019 | Sep 30, 2019 | -71.1% | +115.0 |
| Q2 FY2019CQ2 2019 | Jun 30, 2019 | -79.1% | +52.6 |
| Q1 FY2019CQ1 2019 | Mar 31, 2019 | -127.5% | −61.1 |
| Q4 FY2018CQ4 2018 | Dec 31, 2018 | -199.7% | −142.4 |
| Q3 FY2018CQ3 2018 | Sep 30, 2018 | -186.1% | −153.4 |
| Q2 FY2018CQ2 2018 | Jun 30, 2018 | -131.7% | −82.9 |
| Q1 FY2018CQ1 2018 | Mar 31, 2018 | -66.4% | −52.8 |
| Q4 FY2017CQ4 2017 | Dec 31, 2017 | -57.3% | – |
| Q3 FY2017CQ3 2017 | Sep 30, 2017 | -32.7% | – |
| Q2 FY2017CQ2 2017 | Jun 30, 2017 | -48.8% | – |
| Q1 FY2017CQ1 2017 | Mar 31, 2017 | -13.5% | – |
See a number that looks wrong?